Contemporary Management of HIV 2020

Gain expert insights on the latest data supporting contemporary HIV treatment across settings, including patients who are newly diagnosed, virologically suppressed, or experiencing virologic failure with resistance and/or challenging comorbidities, along with new and emerging ART strategies.
Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD
W. David Hardy, MD
Babafemi Taiwo, MBBS

First-line and Switch Strategies

Gain expert insights on the latest data on the use of contemporary HIV regimens across settings, including for patients who are newly diagnosed and as switch strategies for patients with viral suppression on their current regimen.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD W. David Hardy, MD Babafemi Taiwo, MBBS
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: September 18, 2020 Expired: September 17, 2021

Download this expert-authored slideset to review national guidelines, key study data, and individual considerations for optimizing the use of current ART regimens as initial HIV treatment and in switch strategies for patients with viral suppression who require a change in therapy.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Babafemi Taiwo, MBBS
Released: July 6, 2020

Listen to expert insights from W. David Hardy, MD, on optimizing initial antiretroviral therapy for treatment-naive patients with HIV.

W. David Hardy, MD Released: October 2, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue